Cerapedics’ PearlMatrix P-15 peptide enhanced bone graft earned expanded FDA clearance for lumbar degenerative disc disease in adults.
The new clearance means PearlMatrix is the only Class III drug-device spinal bone graft approved for all major lumbar interbody surgical approaches, according to a Jan. 13 news release. It has indications for one-level ALIF, PLIF, OLIF, LLIF and TLIF.
PearlMatrix is also approved for use with itanium alloy and PEEK/titanium interbody fusion cages cleared by the FDA.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
